Literature DB >> 11680520

Induction of PML immunoreactivity in rat brain neurons after transient middle cerebral artery occlusion.

T Hayashi1, C Sasaki, M Iwai, K Sato, W R Zhang, H Warita, K Abe.   

Abstract

Promyelocytic leukemia (PML) protein is involved in apoptotic death of cultured neuronal cells, but its role in ischemic brain damage remains uncertain. In this study, we investigated change of immunoreactivity for PML protein in rat brain after transient middle cerebral artery occlusion, and compared the results with that of terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick end labeling (TUNEL). Western blotting analysis revealed that PML immunoreactivity was only scant in the sham-control brain, but it increased at 1 h and 1 day after reperfusion, and decreased in density thereafter. Immunohistochemical analysis revealed that nuclei of neurons were most densely stained. TUNEL positive cells appeared at 1 day and peaked at 3 days of reperfusion, indicating that PML protein induction preceded DNA fragmentation in neurons. The present results suggest that PML protein may be one of the key molecules in ischemic neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680520     DOI: 10.1179/016164101101199162

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  3 in total

1.  The Focal-Focal Preconditioning Effect of Photothrombotic Impact on the Signaling Protein Profile in the Penumbra Surrounding the Ischemic Core Induced by Another Photothrombotic Impact.

Authors:  Svetlana V Demyanenko; Anatoly B Uzdensky
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 2.  The role of PML in the nervous system.

Authors:  Paolo Salomoni; Joanne Betts-Henderson
Journal:  Mol Neurobiol       Date:  2010-12-15       Impact factor: 5.590

Review 3.  PML in the Brain: From Development to Degeneration.

Authors:  Erica Korb; Steven Finkbeiner
Journal:  Front Oncol       Date:  2013-09-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.